LEXX Stock Analysis: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$0.57
-0.02 (-2.63%)
▼
5d:
-6.35%
30d:
-6.29%
90d:
-22.26%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 13, 2026
18d
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $0.57, which is considered oversold relative to its 30-day fair value range of $0.58 to $0.64.
Technical Outlook: Technically, LEXX is showing sideways momentum. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LEXX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+560.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEXX is showing sideways momentum. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LEXX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+560.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.58 -
$0.64
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 560.8% below Wall St target ($3.75)
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.58 -
$0.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.72
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.83
Wall Street Target
$3.75
(+560.8%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: June 24, 2026 9:39 AM ET
Data refreshes hourly during market hours. Next update: 10:39 AM
Data refreshes hourly during market hours. Next update: 10:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
